NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN

This article contains a review of Russian and foreign publications with the results of experimental and clinical studies of effectiveness and safety using of a new release active medicine — Ergoferon for the treatment of acute respiratory viral infection (ARVI), including influenza virus. The result...

Full description

Saved in:
Bibliographic Details
Main Author: I. V. Nikolaeva
Format: Article
Language:Russian
Published: LLC "Diagnostics and Vaccines" 2015-08-01
Series:Детские инфекции (Москва)
Subjects:
Online Access:https://detinf.elpub.ru/jour/article/view/54
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850073993593225216
author I. V. Nikolaeva
author_facet I. V. Nikolaeva
author_sort I. V. Nikolaeva
collection DOAJ
description This article contains a review of Russian and foreign publications with the results of experimental and clinical studies of effectiveness and safety using of a new release active medicine — Ergoferon for the treatment of acute respiratory viral infection (ARVI), including influenza virus. The results of investigation of antiviral activities of Ergoferon and its components in adults are presented in the article, as well as absolutely new data about efficacy and safety of a liquid form Ergoferon in ARVI in children.
format Article
id doaj-art-2e6a72aa007748cf8aec2da04f1f76f8
institution DOAJ
issn 2072-8107
language Russian
publishDate 2015-08-01
publisher LLC "Diagnostics and Vaccines"
record_format Article
series Детские инфекции (Москва)
spelling doaj-art-2e6a72aa007748cf8aec2da04f1f76f82025-08-20T02:46:40ZrusLLC "Diagnostics and Vaccines"Детские инфекции (Москва)2072-81072015-08-01133455010.22627/2072-8107-2014-13-3-45-5054NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDRENI. V. Nikolaeva0Kazan State Medical UniversityThis article contains a review of Russian and foreign publications with the results of experimental and clinical studies of effectiveness and safety using of a new release active medicine — Ergoferon for the treatment of acute respiratory viral infection (ARVI), including influenza virus. The results of investigation of antiviral activities of Ergoferon and its components in adults are presented in the article, as well as absolutely new data about efficacy and safety of a liquid form Ergoferon in ARVI in children.https://detinf.elpub.ru/jour/article/view/54ergoferonrelease active drugsacute respiratory viral infection (arvi)antiviral therapychildren
spellingShingle I. V. Nikolaeva
NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN
Детские инфекции (Москва)
ergoferon
release active drugs
acute respiratory viral infection (arvi)
antiviral therapy
children
title NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN
title_full NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN
title_fullStr NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN
title_full_unstemmed NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN
title_short NEW ANTIVIRAL DRUG COMBINED EFFECT OF THERAPY ARVI IN CHILDREN
title_sort new antiviral drug combined effect of therapy arvi in children
topic ergoferon
release active drugs
acute respiratory viral infection (arvi)
antiviral therapy
children
url https://detinf.elpub.ru/jour/article/view/54
work_keys_str_mv AT ivnikolaeva newantiviraldrugcombinedeffectoftherapyarviinchildren